跳至主要内容
临床试验/IRCT201409176691N2
IRCT201409176691N2已完成未知

COMPARISION THE EFFICACY OF ADJUCTIVE THERAPY RISPERIDON OR ARIPIPERAZOL TO LITIUM IN BIPOLAR DISORDER(MANIC PHAZE WITH PSYCHTIC FEATHER)

Mazandaran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • criteria: Age more than 18 years; Diagnosis of Bipolar disorder with psychotic symptom based on DSM-IV TR; Ongoing treatment with Litium as a mood stabilazor with seromic level between 0.8-1.2meq/L ; patient with YMRA>20.Exclusion criteria: Mental Retardation; Pregnancy or Breast Inclusion feeding;Any chronic medical problem; substance abuse; Any other psychiatric Disorder in Axis I OR II;Allergic to Aripiprazole and other Atypical Antipsychotic drug ;History of epileptic disorder; Delirium state.

排除标准

  • 未提供

研究者

相似试验